The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today ...

Shire itself was a proponent of this strategy ... the average drug has now more than doubled to $2 billion and pharma companies need scale to ensure they can deal with expensive failures, while ...

including leadership roles at multinational pharmaceutical companies in the US and internationally and an entrepreneurial career highlighted by his co-founding of Shire Pharmaceuticals.

The IT reseller continued to grow its headcount even when the market was a little subdued ...

The deal is part of Takeda's strategy of becoming a global pharmaceutical company. The Japanese firm wanted to buy Shire to strengthen its cancer, stomach and brain drug portfolios. Takeda chief ...

When we welcomed Shire employees into Takeda ... Insider: Looking forward, how do you see the pharmaceutical company of the future? Weber: Highly scientific. Highly innovative.

David Lee has been inside his fair share of pharmaceutical companies. The 37-year-old exec ... GlaxoSmithKline, Baxter, and Shire. He graduated from Harvard with a degree in biochemistry and ...

Peter has a remarkable track record, including leadership roles at multinational pharmaceutical companies in the US and internationally and an entrepreneurial career highlighted by his co-founding of ...

This FTSE 250 investment trust has taken a different path to its property peers ...

including leadership roles at multinational pharmaceutical companies in the US and internationally and an entrepreneurial career highlighted by his co-founding of Shire Pharmaceuticals.